MD, University of Bologna Medical School (1981). Specialist in Orthopaedics and Traumatology (1987) and in Oncology (1990), University of Bologna Medical School.
Visiting fellow, Alder Hey Children's Hospital, Liverpool (1981). Visiting fellow, Mount Sinai Hospital, Toronto (1986), clinical fellow, Centro Tumori, Istituto Ortopedico Rizzoli in Bologna (1982-88). Research fellow, Department of Orthopaedic Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, Mass (1988-89). Staff, Laboratorio di Ricerca Oncologica, Istituto Ortopedico Rizzoli (1989-99). At the Istituto Ortopedico Rizzoli: staff surgeon, Orthopaedic Oncology, Clinica Ortopedica e Traumatologica I (1999-11); responsible for outpatuient clinic for bone metastases; Head, Orthopaedic Pathophysiology and Regenerative Medicine Lab (2011-20), Musculoskeletal Cell Biology Lab (2018-20), and Nanobiotechnology Lab (2019-now). Head of the Biomedical Science and Technology and Nanobiotechnology Unit (2020-now). Director of the Department Rizzoli-RIT (Research, Innovation & Technology) (2018-now).
Faculty Member, PhD Program in Biomedical and Neuromotor Sciences. Collegio Superiore. Director, Center for Precision Medicine DIBINEM. Chair, Scientific Council of di A.M.A. (Osteoarthritis Movement Association). Chair, Scientific Council of the Interdepartmental Centre for Comparative Oncology.
Visiting Professor, Kyoto Prefectural University of Medicine (2013-18). Consultant of Orthopaedic Oncologu, Istituto Oncologico del Mediterraneo.
Past-President of the European Orthopaedic Research Society, the Connective Tissue Oncology Society, the Italian Orthopaedic Research Society. President, the International Society of Cancer Metabolism.
Honorary member of the Accademia Gioenia. Corresponding member of the Accademia delle Scienze of Bologna.
Author of over 350 peer-reviewed, PubMed indexed papers. H-index (Scopus): 69. Total citations (Scopus): > 19.000.
